Store
Infectious Disease Diagnostic Testing: World Market Analysis, 2022
Publication Date: April 7, 2022
Tags: Infectious Disease Testing Instruments, Infectious Diseases, Pharmaceuticals, Vaccines
Pages: 260
SKU: 22-022
As one of the largest and fastest-growing segments in the in vitro diagnostics (IVD) industry, infectious disease testing is crucial for detecting and identifying pathogens, pinpointing their origins, and determining appropriate antimicrobial therapies.
Kalorama Information’s Infectious Disease Diagnostic Testing: World Market Analysis, 2022 examines market drivers, including external influences that promote the development and use of improved infectious disease diagnostics. The report highlights the global nature of infectious diseases and their impact on both developing and industrialized countries as long-term factors such as aging populations and the increasing burden of infectious diseases strain healthcare resources worldwide.
Report Highlights:
- Product Types: Infectious disease IVD products include reagents, consumables, and instruments based on immunoassays, molecular technologies, and conventional microbiology techniques. Tests are available for detecting hundreds of pathogenic conditions.
- Applications Analyzed:
- Healthcare-associated and opportunistic infections
- Antimicrobial-resistant pathogens (bacteria, fungi, parasites, viruses)
- Human immunodeficiency virus (HIV) and hepatitis viruses
- Women’s health and sexually transmitted infections (STDs)
- Emerging, neglected, and tropical disease threats
- Respiratory tract infections and respiratory viruses (including COVID-19)
Geographic and Country Markets:
- Regions Covered:
- North America
- Eastern Europe
- Western Europe
- Asia/Pacific
- Africa/Middle East
- Central and South America
- Other Regions
Table: Global Infectious Disease IVD Products Demand, by Type, 2026-2031 (in millions $)
| Type | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR |
| Sexually Transmitted Infections (STIs) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Healthcare-Associated Infections (HAIs) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| ID/AST | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Hepatitis | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| HIV/AIDS | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Influenza | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Tuberculosis | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| ToRXH | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Other Infections | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Total World (w/o COVID-19) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| COVID-19 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Total World | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
A Mix of Traditional and Emerging Testing Technologies
Market Drivers
The World Infectious Disease Testing Market
- Table 1-1a: World Infectious Disease Diagnostic Test Market, 2018-2026 ($ millions)
- Table 1-1b: World Infectious Disease Diagnostic Test Market, 2027-2031 ($ millions)
Major Findings of the Report
- Table 1-2: Selected Infectious Diseases, Global Incidence, Prevalence, & Mortality, 2021
Scope and Methodology
Chapter 2: Market Environment
Overview
Population
- Table 2-1a: Population by Country, 2018-2025 (million)
- Table 2-1b: Population by Country, 2026-2031 (million)
Age Distribution
- Table 2-2a: Population 50 Years & Older by Country, 2018-2025 (million)
- Table 2-2b: Population 50 Years & Older by Country, 2026-2031 (million)
- Table 2-3a: Population 65 Years & Older by Country, 2018-2025 (million)
- Table 2-3b: Population 65 Years & Older by Country, 2026-2031 (million)
Macroeconomic Environment
Global Economic Outlook
- Table 2-4a: Gross Domestic Product by Country, 2018-2025 (billion dollars)
- Table 2-4b: Gross Domestic Product by Country, 2026-2031 (billion dollars)
Per Capita Gross Domestic Product
- Table 2-5a: Per Capita Gross Domestic Product by Country, 2018-2025 (dollars)
- Table 2-5b: Per Capita Gross Domestic Product by Country, 2026-2031 (dollars)
Global Healthcare Trends
Infectious Disease Cases
- Table 2-6a: Number of Infectious Disease Cases by Country, 2018-2025 (million)
- Table 2-6b: Number of Infectious Disease Cases by Country, 2026-2031 (million)
- Table 2-7a: Health Expenditures by Country, 2018-2025 (billion dollars)
- Table 2-7b: Health Expenditures by Country, 2026-2031 (billion dollars)
Medical Providers
- Table 2-8 Medical Providers, Selected Countries, 2021
Patient Activity
Hospital Admissions
- Table 2-9a: Hospital Admissions by Country, 2018-2025 (million)
- Table 2-9b.: Hospital Admissions by Country, 2026-2031 (million)
Inpatient Days
- Table 2-10a: Inpatient Days by Country, 2018-2025 (million)
- Table 2-10b: Inpatient Days by Country, 2026-2031 (million)
Surgical Procedures
- Table 2-11a: Surgical Procedures by Country, 2018-2025 (million)
- Table 2-11b: Surgical Procedures by Country, 2026-2031 (million)
Outpatient Consultations
- Table 2-12a: Outpatient Consultations by Country, 2018-2025 (million)
- Table 2-12b: Outpatient Consultations by Country, 2026-2031 (million)
IVD Tests
- Table 2-13a: IVD Tests by Country, 2018-2025 (million)
- Table 2-13b: IVD Tests by Country, 2026-2031 (million)
Chapter 3: Infectious Disease IVD Products & Markets
Overview
- Table 3-1a: Global Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 3-1b: Global Infectious Disease IVD Products Demand by Type, 2026-2031 (million dollars)
Sexually Transmitted Infections (STIs)
- Table 3-2a: Global Sexually Transmitted Infection IVD Products Demand, 2018-2025 (million dollars)
- Table 3-2b: Global Sexually Transmitted Infections IVD Products Demand, 2026-2031 (million dollars)
Chlamydia Trachomatis (chlamydia)
Human Papillomavirus (HPV)
Gonorrhea
Herpes Simplex Virus 2 (HSV-2)
Syphilis
Other Sexually Transmitted Disease (STD) IVD Products
Healthcare-Associated Infections
- Table 3-3a: Global Healthcare-Associated Infection IVD Products Demand, 2018-2025 (million dollars)
- Table 3-3b: Global Healthcare-Associated Infections IVD Products Demand, 2026-2031 (million dollars)
Clostridium difficile (C. diff)
Sepsis
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Vancomycin-Resistant Enterococcus (VRE)
Other HAIs
Identification & Antibiotic Susceptibility Testing (ID/AST) Products
- Table 3-4a: Global ID/AST IVD Products Demand, 2018-2025 (million dollars)
- Table 3-4b: Global ID/AST IVD Products Demand, 2026-2031 (million dollars)
Automated ID/AST Products
Manual Panels & Reagents
Producers
Hepatitis IVD Products
- Table 3-5a: Global Hepatitis IVD Products Demand, 2018-2025 (million dollars)
- Table 3-5b: Global Hepatitis IVD Products Demand, 2026-2031 (million dollars)
HIV/AIDS IVD Products
- Table 3-6a: Global HIV/AIDS IVD Products Demand, 2018-2025 (million dollars)
- Table 3-6b: Global HIV/AIDS IVD Products Demand, 2026-2031 (million dollars)
Influenza
- Table 3-7a: Global Influenza IVD Products Demand, 2018-2025 (million dollars)
- Table 3-7b: Global Influenza IVD Products Demand, 2026-2031 (million dollars)
Tuberculosis (TB)
- Table 3-8a: Global Tuberculosis IVD Products Demand, 2018-2025 (million dollars)
- Table 3-8b: Global Tuberculosis IVD Products Demand, 2026-2031 (million dollars)
TORCH
- Table 3-9a: Global TORCH IVD Products Demand, 2018-2025 (million dollars)
- Table 3-9b: Global TORCH IVD Products Demand, 2026-2031 (million dollars)
All Other Infectious Disease IVD Products
- Table 3-10a: Global Other Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
- Table 3-10b: Global Other Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Malaria
Streptococcal Infections
Fungal Infections
Parasitic Conditions
Lyme Disease
Respiratory Syncytial Virus (RSV)
Emerging Infections
Chikungunya
Dengue Fever
Additional Products
COVID-19
- Table 3-11 Global COVID-19 IVD Products Demand, 2018-2026 (million dollars)
Global Infectious Disease IVD Technologies
- Table 3-12a: Global Infectious Disease IVD Products Demand by Technology, 2018-2025 (million dollars)
- Table 3-12b: Global Infectious Disease IVD Products Demand by Technology, 2026-2031 (million dollars)
Immunoassays
- Table 3-13a: Global Immunoassay Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
- Table 3-13b: Global Immunoassay Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Molecular Technologies
- Table 3-14a: Global Molecular Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
- Table 3-14b: Global Molecular Infectious Disease IVD Products Demand 2026-2031 (million dollars)
Conventional Microbiology
- Table 3-15a: Global Microbiology Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
- Table 3-15b: Global Microbiology Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Global Infectious Disease IVD Demand by Market
- Table 3-16a: Global Infectious Disease IVD Products Demand by Site, 2018-2025 (million dollars)
- Table 3-16b: Global Infectious Disease IVD Products Demand by Site, 2026-2031 (million dollars)
- Table 3-17a: Global Laboratory Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
- Table 3-17b: Global Laboratory Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
- Table 3-18a: Global Point-of-Care Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
- Table 3-18b: Global Point-of-Care Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
TEST TABLES
All Sexually Transmitted Infections
All Healthcare-Associated Infections
All ID/AST
All Hepatitis
All HIV/AIDS
All Influenza
All Tuberculosis
All TORCH
All Other Infections
All Total World (w/o COVID-19)
All COVID-19
SDI Test
Technology:
Immunoassay, 2018-2031
Molecular, 2018-2031
Microbiology, 2018-2031
Site:
Laboratory Tests, 2018-2031
POC Tests , 2018-2031
Pathogen:
Chlamydia, 2018-2031
HPV, 2018-2031
Gonorrhea, 2018-2031
HSV-2 (Herpes Simplex), 2018-2031
Syphilis, 2018-2031
Other STIs, 2018-2031
HAI TESTS
Technology, 2018-2031
Microbiology, 2018-2031
Immunoassay, 2018-2031
Molecular, 2018-2031
Site:
Laboratory Tests, 2018-2031
POC Tests , 2018-2031
Pathogen/Disorder:
- diff, 2018-2031
Sepsis, 2018-2031
MRSA, 2018-2031
VRE, 2018-2031
Other HAIs, 2018-2031
Total World, 2018-2031
ID/AST
Automated Tests, , 2018-2031
Manual Tests, 2018-2031
Total World, , 2018-2031
HEPATITIS
Technology:
Immunoassay, 2018-2031
Molecular, 2018-2031
Site:
Laboratory Tests, 2018-2031
Blood Screens, 2018-2031
POC Tests, 2018-2031
Pathogen/Disorder:
Hepatitis B , 2018-2031
Hepatitis C, 2018-2031
Other, 2018-2031
Total World, 2018-2031
HIV/AIDS
Technology:
Immunoassay, 2018-2031
Molecular, 2018-2031
Site:
Laboratory Tests, 2018-2031
Blood Screens, 2018-2031
POC Tests, 2018-2031
Total World, 2018-2031
INFLUENZA
Technology:
Immunoassay, 2018-2031
Molecular, 2018-2031
Microbiology, 2018-2031
Site:
Laboratory Tests, 2018-2031
POC Tests, 2018-2031
Total World, 2018-2031
TUBERCULOSIS
Technology:
Molecular, 2018-2031
Microbiology, 2018-2031
Immunoassay, 2018-2031
Total World, 2018-2031
TORCH TESTING
Total World, 2018-2031
EMERGING AND OTHER
Malaria, 2018-2031
Streptococcal, 2018-2031
Fungal, 2018-2031
Parasitic, 2018-2031
Lyme Disease, 2018-2031
RSV, 2018-2031
Emerging Infections, 2018-2031
Dengue fever, 2018-2031
All Other, 2018-2031
Total World, 2018-2031
COVID-19
Molecular Tests, 2018-2031
Immunoassays, 2018-2031
Chapter 4: Global Markets
Overview
- Table 4-1a: Infectious Disease IVD Products Demand by Country, 2018-2025 (million dollars)
- Table 4-1b: Infectious Disease IVD Products Demand by Country/Region, 2026-2031 (million dollars)
North America
- Table 4-2a: North America: Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
- Table 4-2b: North America: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
United States
- Table 4-3a: United States: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-3b: United States: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Canada
- Table 4-4a: Canada: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-4b: Canada: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Mexico
- Table 4-5a: Mexico: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-5b: Mexico: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Western Europe
- Table 4-6a: Western Europe: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-6b: Western Europe: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Germany
- Table 4-7a: Germany: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-7b: Germany: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
France
- Table 4-8a: France: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-8b: France: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
United Kingdom
- Table 4-9a: United Kingdom: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-9b: United Kingdom: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Italy
- Table 4-10a: Italy: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-10b: Italy: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Spain
- Table 4-11a: Spain: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-11b: Spain: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Other Western Europe
- Table 4-12a: Other Western Europe: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-12b: Other Western Europe: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Netherlands
Belgium
Sweden
Austria
Switzerland
Norway
Denmark
Portugal
Ireland
Greece
Finland
All Other Countries & Territories
Asia/Pacific
- Table 4-13a: Asia/Pacific: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-13b: Asia/Pacific: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
China
- Table 4-14a: China: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-14b: China: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
India
- Table 4-15a: India: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-15b: India: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Japan
- Table 4-16a: Japan: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-16b: Japan: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
South Korea
- Table 4-17a: South Korea: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-17b: South Korea: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Other Asia/Pacific
- Table 4-18a: Other Asia/Pacific: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-18b: Other Asia/Pacific: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Indonesia
Australia
Philippines
Thailand
Taiwan
Vietnam
Malaysia
Pakistan
Hong Kong
Singapore
New Zealand
All Other Countries & Territories
Other Regions
- Table 4-19a: Other Regions: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-19b: Other Regions: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Central & South America
- Table 4-20a: Central & South America: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-20b: Central & South America: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Brazil
Argentina
Colombia
Peru
Chile
All Other Countries & Territories
Eastern Europe
- Table 4-21a: Eastern Europe: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-21b: Eastern Europe: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Russia
Poland
Romania
Czech Republic
Hungary
All Other Countries
Africa/Middle East
- Table 4-22a: Africa/Middle East: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
- Table 4-22b: Africa/Middle East: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
Turkey
Saudi Arabia
Iran
Egypt
Iraq
Nigeria
South Africa
Israel
United Arab Emirates
All Other Countries & Territories
Chapter 5: Company Profiles
Abbott Laboratories
Becton Dickinson and Company
Bio-Rad Laboratories
bioMérieux
Bruker Corporation
Danaher Corporation
DiaSorin
Grifols S.A.
Hologic
Ortho Clinical Diagnostics Holdings
QIAGEN
Quidel Corporation
Roche Holding
Immunoassays
COVID-19
Siemens Healthineers
Thermo Fisher Scientific
Microbiology
COVID-19
Related products
30-Country In Vitro Diagnostic (IVD) Market Atlas [October 2023 Update]
October 27, 2023
The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.
Key…
$5,000.00 – $7,500.00
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition
April 23, 2024
Explore the latest trends and forecasts in the point-of-care (POC) diagnostic tests market with Kalorama Information’s The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. Discover the key growth areas and technological advancements shaping the future of POC diagnostics.
Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in…
$7,000.00 – $10,000.00
The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition
March 7, 2024
Explore the cutting-edge world of molecular point-of-care (mPOC) diagnostic solutions with our latest report, offering a detailed analysis of the market and future growth potential from 2023-2028. mPOC technology revolutionizes diagnostic capabilities, providing enhanced sensitivity and specificity compared to traditional near-patient tests. These solutions are instrumental in critical care units, physician offices, outpatient clinics,…
$5,000.00 – $7,875.00
